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Anti- microbial activityAbstract A series of new 1,4 disubstituted (1-alkyl-1H-1,2,3-triazol-4-yl)methyl-2H-chromene-3-
carboxylates (4ai–4eiii) have been efﬁciently synthesized in moderate to excellent yields by the
1,3 dipolar cycloaddition between 2-propynyl-2H-chromene-3-carboxylates 3a–e and various alkyl
azides under Cu(I) catalyzed conditions. The structures of the synthesized compounds are estab-
lished based on IR, NMR, MASS Spectrometric methods and elemental analyses. The antibacterial
and antifungal activities of synthesized compounds were evaluated. Compounds 4biii,4ei, 4dii, 4ai,
4aii, 4bii showed good activity against bacterial strains and the compounds 4bi, 4eii against fungal
strains.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Chromenes, 2H-1-benzopyran derivatives, widely used as
important intermediates in the synthesis of many natural prod-
ucts and medicinal agents (Passkeiter et al., 1992; Narkhede
et al., 1990; Engler et al., 1993). There has been interest in the
use of these structural elements for a new family of potassium
channel activity drugs (Elomri et al., 1996; Atwal et al., 1995;
Van Lommen et al., 1990). 1,2,3-Triazoles have been widelyused in synthetic intermediates and industrial applications, such
as dyes, anti calmative agents, photostabilisers, photographic
elements and agrochemicals (Pinhua and Lei, 2007). 1,2,3-Tria-
zoles also display biological activities as anti HIV (Alrarez et al.,
1994), b-lactamase inhibitory (Micetich et al., 1987), selective b3
adrenergic receptor agonists (Brockunier et al., 2000). As struc-
tural elements in drugs, 1,2,3-triazole moiety is aromatic with
high chemical and metabolic stability, has a D.M of 5.2–5.6 D
and the hydrogen bond accepting ability, capacity to participate
in dipole–dipole interactions as well as p staking interactions,
hence a good candidate for bioisosteric replacement in existing
drugs or in the development of lead structures (Tron et al.,
2007). Numerous synthetic methods for the preparation of
1,2,3-triazole derivatives have been developed (Jiang et al.,
2009, 2011). Among them Huisgen 1,3-dipolar cycloaddition
between an alkyne and azide is the classical and extensively used
method (Finley and Montgomery, 1980). However, the
Synthesis and anti-microbial activity 373regioselectivity of this cycloaddition reaction is low and the
reaction leads to the mixture of 1,4 and 1,5-regioisomers
(Huisgen and Padwa, 1984; Howell et al., 2001). The regioselec-
tivity of the reaction improved by Cu(I) catalyzed ligation (click
chemistry) of organic azides and terminal alkynes (Rostovtsex
et al., 2002; Tornee et al., 2002; Bock et al., 2006). Exclusive reg-
ioselectivity, mild reaction conditions, effective catalytic
system, wide substrate scope and high yields are the main
advantages of this reaction.
In view of wide range of applications of triazoles and
chromenes, we synthesized novel mixed heterocyclic com-
pounds having 1,2,3-triazole and chromene, using 2-propy-
nyl-2H-chromene-3-carboxylates as scaffolds by adopting
Cu(I) catalyzed click chemistry. The products are exclusively
1,4-disubstituted regioisomers. A series of (1-alkyl-1H-1,
2,3-triazol-4-yl) methyl 2H-chromene-3-carboxylate analogues
modiﬁed in the 6th and 8th position were prepared. All the
synthesized compounds evaluated for anti microbial activity.
2. Experimental
2.1. General
Compounds 2H-3-chromenecarbonitriles 1a–e, and
2H-3-chromenecarboxylic acids (Subramanian, 2001) 2a–e
and azides (Escaicu et al., 2008) are prepared by reported
procedure.Allmelting pointswere obtained on aPolmon instru-
ment, India (modelMP96) and are uncorrected. IR spectrawere
recorded on a Fourier transform (FT)-IR, USA (Perkin-Elmer
model 337) instrument. 1H and 13CNMR spectra were recorded
on Bruker 400 MHz and 300 MHz, Switzerland using TMS as
an internal standard. J-Values are given in Hz. Mass spectral
data were obtained with Agilent 6310 ion trap mass spectrome-
ter, USA.
2.2. General procedure for synthesis of 2-propynyl 2H-3-
chromenecarboxylates (3a–e)
A mixture of 2H-3-chromenecarboxylic acids 2a–e (17.04
mmol) and excess of SOCl2 (5 mL) in 50 ml of dry benzene
was heatedunder reﬂux for 2 hwith stirring. The excess of SOCl2
was removed under reduced pressure. The reaction mixture was
cooled under N2 atmosphere and dissolved in dry CH2Cl2,
added propargyl alcohol (25.50 mmol) and basiﬁed the reaction
mixture with triethylamine (5 mL) and stirring maintained at
ambient temperature for 6 h. After completion of the reaction
another 100 ml of CH2Cl2 was added and washed with dil HCl
to remove triethylamine and ﬁnallywashedwithwater and dried
over anhydrousNa2SO4. The crude product was puriﬁed by col-
umn chromatography to afford pure compounds 3a–e.
2.2.1. 20-Propynyl 2H-3-chromenecarboxylate (3a)
Yield: 62%; white solid; Mp: 48–50 C; IR (KBr): 1685 cm1
(C‚O), 2150 cm1 (C„C); 1H NMR (CDCl3, 300 MHz): d
7.53 (1H, s, H-4), 7.21 (1H, ddd, J= 8.1 Hz, J= 7.3 Hz,
J= 1.3 Hz, H-7), 7.12 (1H, d, J= 7.5 Hz, H-5), 6.97(1H,
ddd, J= 1.3 Hz, J= 7.5 Hz, J= 7.3 Hz, H-6), 6.82 (1H, d,
J= 8.1 Hz, H-8), 4.99 (2H, s, OCH2), 4.79 (2H, d,
J= 2.4 Hz, COOCH2), 2.77 (1H, t, J= 2.4 Hz, C„CH);
13C NMR (CDCl3, 75.5 MHz): d 163.4 (C‚O), 155.1(C-8(a), 134.5 (C-7), 132.1 (C-4), 128.9 (C-5), 121.6 (C-6),
121.3 (C-3), 120.5 (C-4(a), 116.0 (C-8), 77.4 (C-40), 75.1 (C-
50), 64.1 (C-2), 52.0 (C-30); MS: m/z 215[M+H]+; Anal. Calc.
for C13H10O3: C, 72.89; H, 4.71. Found: C, 72.78; H, 4.85%.2.2.2. 20-Propynyl 6-methyl 2H-3-chromenecarboxylate (3b)
Yield: 68%; white solid; Mp: 70–72 C; IR (KBr): 1680 cm1
(C‚O), 2160 cm1 (C„C); 1H NMR (CDCl3, 300 MHz): d
7.48 (1H, s, H-4), 7.04 (1H, dd, J= 8.4 Hz, J= 2.0 Hz, H-
7), 6.59 (1H, d, J= 2.0 Hz, H-5), 6.75 (1H, d, J= 8.4 Hz,
H-8), 4.97 (2H, s, OCH2), 4.82 (2H, d, J= 2.4 Hz,
COOCH2), 2.52 (1H, d, J= 2.4 Hz, C„CH), 2.27 (3H, s,
6-CH3);
13C NMR (CDCl3, 75.5 MHz): d 163.6 (C‚O),
153.0 (C-8(a), 134.8 (C-7), 132.7 (C-5), 131.0 (C-3), 129.2
(C-4), 121.4 (C-4), 121.4 (C-6), 120.5 (C-4(a), 115.8 (C-8),
77.5 (C-40), 75.0 (C-50), 64.1 (C-2), 52.1 (C-30), 20.3 (6-
CH3); ESIMS: m/z 229[M+H]
+; Anal. Calc. for
C14H12O3: C, 73.67; H, 5.30. Found: C, 73.78; H, 5.44%.2.2.3. 20-Propynyl 6-chloro 2H-3-chromencarboxylate (3c)
Yield: 64%; white solid; Mp: 92–94 C; IR (KBr): 1685 cm1
(C‚O), 2150 cm1 (C„C); 1H NMR (CDCl3, 300 MHz): d
7.39 (1H, s, H-4), 7.16 (1H, dd, J= 8.4 Hz, 2.4 Hz, H-7),
7.11 (1H, d, J= 2.4 Hz, H-6), 6.76 (1H, d, J= 8.4 Hz, H-
8), 4.98 (2H, s, OCH2), 4.79 (d, J= 2.4 Hz, COOCH2),
2.46 (t, J= 2.4 Hz, C„CH); 13C NMR (CDCl3,
75.5 MHz): d 163.1 (C‚O), 153.5 (C-8(a), 133.1 (C-7),
131.6 (C-5), 128.1 (C-4), 126.4 (C-3), 122.6 (C-4(a), 121.7
(C-6), 117.4 (C-8), 77.4 (C-40), 75.2 (C-50), 64.3 (C-2), 52.2
(C-30); ESIMS: m/z 249[M+H]+; Anal. Calc. for C13H9ClO3:
C, 62.79; H, 6.65. Found: C, 62.87; H, 6.74%.2.2.4. 20-Propynyl 6-methoxy 2H-3-chromenecarboxylate (3d)
Yield: 70%; yellow solid; Mp: 108–110 C; IR (KBr):
1685 cm1 (C‚O), 2150 cm1 (C„C); 1H NMR (CDCl3,
300 MHz): d 7.48 (1H, s, H-4), 6.81 (2H, m, H-8, H-7),
6.70 (1H, d, J= 2.4 Hz, H-5), 4.95 (2H, s, OCH2), 4.82
(2H, d, J= 2.4 Hz, COOCH2), 3.77 (3H, s, 6-OCH3), 2.52
(1H, d, J= 2.4 Hz, C„CH); 13C NMR (CDCl3,
75.5 MHz): d 163.5 (C‚O), 154.2 (C-8(a), 149.1 (C-6),
134.6 (C-4), 122.3 (C-3), 121.2 (C-4(a), 118.0 (C-7), 116.8
(C-5), 113.0 (C-8), 77.4 (C-4), 75.1 (C-50), 64.1 (C-2), 55.6
(6-CH3), 52.1 (C-3
0); ESIMS: m/z 245[M+H]+; Anal. Calc.
for C14H12O4: C, 68.85; H, 4.95. Found: C, 68.96; H, 4.87%.2.2.5. 20-propynyl 8-methoxy 2H-3-chromenecarboxylate (3e)
Yield: 65%; yellow solid; Mp: 82–84 C; IR (KBr): 1685 cm1
(C‚O), 2150 cm1 (C„C); 1H NMR (CDCl3, 300 MHz): d
7.54 (1H, s, H-4), 6.94 (2H, m, H-7, H-5), 6.77 (1H, m, H-
6), 4.86(2H, s, OCH2), 4.79 (2H, d, J= 2.4 Hz, COOCH2),
3.78(3H, s, 8-OCH3), 2.50 (1H, d, J= 2.4 Hz, C„CH);
13C
NMR (CDCl3, 75.5 MHz): d 163.3 (C‚O),147.7 (C-8), (C-
8(a), 144.0 (C-3),134.4 (C-6), 121.3 (C-4), 121.2 (C-4(a),
120.8 (C-5), 114.6 (C-7), 77.3 (C-40), 75.0 (C-50), 64.3 (C-2),
55.9 (8-OCH3), 52.0 (C-3
0); ESIMS: m/z 245[M+H]+; Anal.
Calc. for C14H12O4: C, 68.85; H, 4.95. Found: C, 68.91; H,
4.91%.
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triazol-4-yl)methyl 2H-3-chromenecarboxylates (4ai–4eiii)
2-Propynyl 2H-3-chromenecarboxylates 3a–e (10 mmol) and
alkyl azide (i–iii) 10 mmol) were suspended in a 1:1 mixture
of water and tert-butyl alcohol (20 mL). Sodium ascorbate
(300 lL of freshly prepared 1 M solution in water) was
added, followed by copper (II) sulfate pentahydrate
(0.03 mmol, in 100 lL of water). The heterogeneous mixture
was stirred vigorously overnightand TLC analysis indicated
complete consumption of the reactants. The reaction mixture
was diluted with water (100 mL), cooled in ice and the
white precipitate was collected by ﬁltration. After washing
the precipitate with cold water (2 · 25 mL), it was dried




Yield: 91%; white solid; Mp: 127 C; IR (KBr): 1725 cm1
(C‚O); 1H NMR: (DMSO-d6, 400 MHz): d 8.30 (1H, s, H-
50), 7.52 (1H, s, H-4), 7.38–7.33 (6H, m, H-200, H-600,H-300, H-
400, H-500,H-5), d 7.28 (1H, ddd, J= 7.6 Hz, J= 8.0 Hz,
J= 1.6 Hz, H-7), d 6.96(1H, ddd, J= 7.6 Hz, J= 7.2 Hz,
J= 1.6 Hz, H-6), d 6.86 (1H, d, J= 8.0 Hz, H-8), d 5.61
(2H, s, NACH2), d 5.28 (2H, COOCH2), d 4.93 (2H, s,
OCH2);
13C NMR (CDCl3, 75.5 MHz): d 164.1 (C‚O),
154.9 (C-8(a), 142.8 (C-40), (C-100), 134.2 (C-7), 131.9 (C-4),
128.9 (C-5), 128.8 (C-300), (C-500), 128.6 (C-200), (C-600), 127.9
(C-40), 123.7 (C-50), 121.6 (C-6),120.5 (C-3),(C-4(a),115.9 (C-
8), 64.1 (C-2), 57.6 (CH2AOAC‚O), 54.0 (NACH2APh);
ESIMS: m/z 348[M+H]+; Anal. Calc. for C20H17N3O3: C,
69.15; H, 4.93; N, 12.10. Found: C, 69.09; H, 4.78; N, 12.17%.
2.3.2. [1-(2-Morpholino-2-oxoethyl)-1H-1,2,3-triazol-4-
yl]methyl 2H-3-chromenecarboxylate (4aii)
Yield: 86%; white solid; Mp: 185–186 C; IR (KBr): 1690 cm1
(CON), 1730 cm1 (COO); 1H NMR (DMSO-d6, 300 MHz): d
8.12 (1H, s, H-50), 7.53 (1H, s, H-4),7.37 (1H, dd, J= 7.4 Hz,
J= 1.3 Hz, H-5), 7.29 (1H, ddd, J= 8.3 Hz, J= 7.5 Hz,
J= 1.3 Hz, H-7), 6.96 (1H, dd, J= 7.5 Hz, J= 7.4 Hz, H-
6), 6.85 (1H, d, J= 8.3 Hz, H-8), 5.50 (2H, s, NACH2), 5.32
(2H, s, COOCH2), 4.94 (2H, s, OCH2), 3.56–3.68 (4H, 2t,
J= 4.3 Hz, O(CH2)2), 3.42–3.54 (4H, 2t, J= 4.3 Hz,
N(CH2)2);
13C NMR (CDCl3, 75.5 MHz): d 164.1 (NAC‚O),
163.3 (OAC‚O), 155.1 (C-8(a), 142.8 (C-40), 134.3 (C-7),
132.0 (C-4), 128.9 (C-5), 125.6 (C-6), 121.7 (C-50), 120.6
(C-4(a), (C-3), 116.0 (C-8), 66.4 (C-300), 66.1 (C-500), 64.2
(C-2), 57.6 (CH2AOAC‚O), 50.6 (NACH2APh), 45.5
(C-200), 42.2 (C-600); ESIMS: m/z 385[M+H]+; Anal. Calc.
for C19H20N4O5: C, 59.37; H, 5.24; N, 14.58. Found: C,
59.49; H, 5.13; N, 12.17%.
2.3.3. [1-(3-Morpholino-3-oxopropyl)-1H-1,2,3-triazol-4-
yl]methyl 2H-3-chromenecarboxylate (4aiii)
Yield: 92%; white solid; Mp: 96–98 C; IR (KBr): 1685 cm1
(CON), 1720 cm1 (COO); 1H NMR (DMSO-d6, 300 MHz):
d 8.19 (1H, s, H-50), 7.52 (1H, s, H-4), 7.36 (1H, dd,
J= 7.4 Hz, J= 1.4 Hz, H-5), 7.29 (1H, ddd, J= 8.4 Hz,
J= 7.5 Hz, J= 1.3 Hz, H-7), 6.96 (1H, dd, J= 7.5 Hz,J= 7.4 Hz, H-6), 6.86 (1H, d, J= 8.4 Hz, H-8), 5.28 (2H, s,
COOCH2), 4.93 (2H, s, OCH2), 4.58 (2H, t, J= 5.4 Hz,
NACH2), 3.52 (4H, m, 300,500-(CH2)2), 3.42 (m, 200,600- (CH2)2),
2.99 (2H, t, J= 5.4 Hz, CH2CO);
13C NMR (CDCl3,
75.5 MHz): d 167.7 (NAC‚O), 164.0 (OAC‚O), 154.9 (C-
8(a), 142.1 (C-3), (C-40), 134.1 (C-7), 131.9 (C-4), 128.8 (C-5),
125.2 (C-6), 121.6 (C-50), 120.6 (C-4(a), 115.9 (C-8(a), 66.4
(C-300), 66.1 (C-500), 64.1 (C-2), 45.7 (C-200), 45.4 (C-600), 41.8
(NACH2), 32.9 (O‚CACH2); ESIMS: m/z 399[M+H]
+.
Anal. Calc. for C20H22N4O5: C, 60.29; H, 5.57; N, 14.06.
Found: C, 60.18; H, 5.65; N, 14.15%.
2.3.4. (1-Benzyl-1H-1,2,3-triazol-4-yl)methyl-6-methyl-2H-3-
chromenecarboxylate (4bi)
Yield: 92%; white solid; Mp: 137–139 C; IR (KBr): 1680 cm1
(C‚O); 1H NMR (CDCl3, 400 MHz): d 8.28 (1H, s, H-50),
7.46 (1H, s, H-4), 7.39–7.33 (5H, m, H-200,300,400,500,600), 7.16
(1H, d, J= 2.1 Hz, H-5), 7.09 (1H, dd, J= 8.4 Hz,
J= 2.1 Hz, H-7), 6.76 (1H, d, J= 8.4 Hz, H-8), 5.61 (2H, s,
NACH2), 5.24 (2H, s, COOCH2), 4.83 (2H, s, OCH2), 2.21
(3H, s, 6-CH3);
13C NMR (CDCl3, 75.5 MHz): d 164.2
(C‚O), 152.9 (C-8(a),143.0 (C-40), 134.4 (C-7),134.2 (C-100),
132.6 (C-5), 130.9 (C-300), 129.1 (C-4), 129.0 (C-200),128.7 (C-
400), 128.0 (C-50), 123.7 (C-3), 121.7 (C-6), 120.5 (C-4(a),
115.7 (C-8), 64.1 (C-2), 57.6 (CH2AOAC‚O), 54.1
(NACH2APh), 20.2 (6-CH3); ESIMS: m/z 362[M+H]
+; Anal.
Calc. for C21H19N3O3: C, 69.79; H, 5.30; N, 11.63. Found: C,
69.86; H, 5.19; N, 11.72%.
2.3.5. [1-(2-Morpholino-2-oxoethyl)-1H-1,2,3-triazol-4-
yl]methyl 6-methyl-2H-3-chromenecarboxylate (4bii)
Yield: 88%; white solid; Mp: 172–174 C; IR (KBr): 1685 cm1
(CON), 1725 cm1 (COO); 1H NMR (DMSO-d6, 300 MHz): d
8.10 (1H, s, H-50), 7.48 (1H, s, H-4),7.16 (1H, d, J= 1.2 Hz,
H-5), 7.09 (1H, dd, J= 8.1 Hz, J= 1.2 Hz, H-7), 6.76
(1H, d, J= 8.1 Hz, H-8), 5.49 (2H, s, NACH2), 5.31 (2H, s,
COOCH2), 4.88 (2H, s, OCH2), 3.66–3.57 (4H, 2t,
J= 4.2 Hz, O(CH2)2), 3.45–3.53 (4H, 2t, J = 4.2 Hz,
N(CH2)2);
13C NMR (CDCl3, 75.5 MHz): d 164.2 (NAC‚0),
163.3 (OAC‚O), 152.9 (C-8(a), 142.9 (C-40), 134.5 (C-7),
132.6 (C-4), 131.0 (C-3), 129.1 (C-5), 125.6 (C-50), 121.7
(C-6), 120.5 (C-4(a), 115.7 (C-8), 66.4 (C-300), 66.1 (C-500), 64.1
(C-2), 57.6 (CH2AOAC‚O), 50.6 (NACH2APh), 45.5
(C-200), 42.4 (C-600), 20.3 (6-CH3); ESIMS: m/z 399[M+H]
+;
Anal. Calc. for C20H22N4O5: C, 60.29; H, 5.57; N, 14.06.
Found: C, 60.18; H, 5.63; N, 14.15%.
2.3.6. [1-(3-Morpholino-3-oxopropyl)-1H-1,2,3-triazol-4-
yl]methyl 6-methyl-2H-3-chromenecarboxylate (4biii)
Yield: 91%; white solid; Mp: 125–127 C; IR (KBr): 1680 cm1
(CON), 1730 cm1 (COO); 1H NMR (DMSO-d6, 400 MHz): d
8.19 (1H, s, H-50),7.46 (1H, s, H-4),7.15 (1H, d, J= 1.3 Hz, H-
5), 7.09 (1H, dd, J= 7.6 Hz, J= 1.3 Hz, H-7), 6.76 (1H, d,
J= 8.2 Hz, H-8), 5.28 (2H, s, COOCH2), 4.88 (2H, s,
OCH2), 4.58 (2H, t, J= 5.1 Hz, NACH2), 3.52 (4H, m,
300,500-(CH2)2), 3.40 (4H, m, 200,600A(CH2)2), 3.0 (2H, t,
J= 5.1 Hz, CH2CO);
13C NMR (CDCl3, 75.5 MHz): d 167.7
(NAC‚O), 164.2 (OAC‚O), 152.9 (C-8(a), 142.3 (C-4(a),
134.4 (C-7),132.6 (C-5),131.0 (C-3), 129.1 (C-4), 125.2 (C-50),
121.7 (C-6), 120.5 (C-4(a), 115.7 (C-8), 66.5 (C-300), 66.2
Synthesis and anti-microbial activity 375(C-500), 64.1 (C-2), 57.6 (CH2AOAC‚O), 45.8 (C-200), 45.5 (C-
600), 41.9 (NACH2APh), 33.0 (CH2AC‚O), 20.3 (6-CH3); ESI
MS: m/z 413[M+H]+; Anal. Calc. for C21H24N4O5: C, 61.16;
H, 5.87; N, 13.58. Found: C, 61.07; H, 5.94; N, 13.71%.
2.3.7. (1-Benzyl-1H-1,2,3-triazol-4-yl)methyl 6-chloro-2H-3-
chromenecarboxylate (4ci)
Yield: 90%; white solid; Mp: 141–143 C; IR (KBr): 1685 cm1
(C‚O); 1H NMR (DMSO-d6, 300 MHz): d 8.24 (1H, s, H-50),
7.50 (1H, s, H-4), 7.48 (1H, d, J= 1.6 Hz, H-5), 7.39–7.28
(6H, m, H-200,300,400,500,600,7), 6.98 (1H, d, J= 8.2 Hz, H-8),
5.61 (2H, s, NACH2), 5.31 (2H, s, COOCH2), 4.99 (2H, s,
OCH2);
13C NMR (CDCl3, 75.5 MHz): d 163.8 (C‚O),
153.5 (C-8(a), 142.7 (C-40), 134.2 (C-100), 132.9 (C-7),131.5
(C-300),129.0 (C-200),128.7 (C-400),128.0 (C-5),(C-50),126.3 (C-
3), 123.7 (C-4), 123.0 (C-4(a), 121.8 (C-6), 117.3 (C-8), 64.3
(C-2), 57.8 (CH2AOAC‚O), 54.1 (NACH2APh); ESIMS:
m/z 382[M+H]+; Anal. Calc. for C20H16ClN3O3: C, 62.91;
H, 4.22; N, 11.01. Found: 62.86; H, 4.29; N, 11.12%.
2.3.8. [1-(2-Morpholino-2-oxoethyl)-1H-1,2,3-triazol-4-
yl]methyl 6-chloro-2H-3-chromenecarboxylate (4cii)
Yield: 91%; white solid; Mp: 184–186 C; IR (KBr): 1680 cm1
(CON), 1730 cm1 (COO); 1H NMR (CDCl3, 300 MHz): d
8.11 (1H, s, H-50), 7.52 (1H, s, H-4), 7.50 (1H, d,
J= 2.7 Hz, H-5), 7.30 (1H, dd, J= 8.4 Hz, J= 2.7 Hz, H-
7), 6.88 (1H, d, J= 8.4 Hz, H-8), 5.50 (2H, s, NACH2), 5.32
(2H, s, COOCH2), 4.96 (2H, s, OCH2), 3.65–3.57 (4H, 2t,
J= 4.2 Hz, O(CH2)2), 3.53–3.32 (4H, 2t, J= 4.2 Hz,
N(CH2)2);
13C NMR (CDCl3, 75.5 MHz): d 163.9 (NAC‚0),
163.3 (OAC‚O), 153.6 (C-8(a), 142.7 (C-40), 133.0 (C-7),
131.5 (C-5), 128.1 (C-50), 126.4 (C-3), 125.7 (C-4), 123.1 (C-
6), 121.9 (C-4(a), 117.4 (C-8), 66.5 (C-300), 66.2 (C-500), 64.4
(C-2), 57.8 (CH2AOAC‚O), 50.6 (NACH2APh), 45.7 (C-
200), 42.5 (C-600); ESIMS: m/z 419[M+H]+; Anal. Calc. for
C19H19Cl N4O5: C, 54.49; H, 4.57; N, 13.58. Found: C,
54.38; H, 4.66; N, 13.29%.
2.3.9. [1-(3-Morpholino-3-oxopropyl)-1H-1,2,3-triazol-4-
yl]methyl 6-chloro-2H-3- chromenecarboxylate (4ciii)
Yield: 88%;Yellowsolid;Mp: 147–150 C; IR (KBr): 1680 cm1
(CON), 1715 cm1 (COO); 1HNMR (CDCl3, 300 MHz): d 8.19
(1H, s, H-50), 7.51 (1H, s, H-4), 7.49 (1H, d, J= 1.7 Hz, H-
5),7.31 (1H, dd, J= 8.4 Hz, H-7), 6.89 (1H, d, J= 8.4 Hz, H-
8), 5.28 (2H, s, COOCH2), 4.97 (2H, s, OCH2), 4.58 (2H, t,
J= 4.6 Hz, NACH2), 3.51 (4H, m, 300,500-(CH2)2), 3.42 (4H, m,
200,600-(CH2)2), 2.99 (2H, t, J= 4.6 Hz, CH2CO);
13C NMR
(CDCl3, 75.5 MHz): d 167.7 (NAC‚O), 163.7 (OAC‚O),
153.4 (C-8(a), 141.9 (C-40), 132.8 (C-7), 131.4 (C-5), 128.0 (C-50),
126.3 (C-3), 125.3 (C-4), 123.0 (C-6), 121.8 (C-4(a), 117.3 (C-8),
66.5 (C-300), 66.1 (C-500), 64.3 (C-2), 57.7 (CH2AOAC‚O), 45.8
(C-200), 45.5 (C-600), 41.9 (NACH2APh), 32.9 (CH2AC‚O);
ESIMS: m/z 433[M+H]+ and 434[M+H+2]; Anal. Calc. for




Yield: 88%; white solid; Mp: 109–111 C; IR (KBr): 1685 cm1
(C‚O); 1H NMR (DMSO-d6, 300 MHz): d 8.28 (1H, s, H-50),
7.50 (1H, m, H-7), 7.35–7.33 (5H, m, H-200,300,400, 500,600), 7.01(1H, s, H-4), 6.83 (1H, d, J= 8.3 Hz, H-8), 5.61 (2H, s,
NACH2), 5.28 (2H, s, COOCH2), 4.85 (2H, s, OCH2), 3.69
(3H, s, 6-OCH3);
13C NMR (CDCl3, 75.5 MHz): d 164.0
(C‚O), 154.1 (C-8(a), 142.7 (C-40), 134.2 (C-300, C-500), 128.9
(C-200), (C-600), 128.6 (C-400), 127.9 (C-50), 123.7 (C-4), 122.5
(C-3, C-100), 121.1 (C-4(a), 117.7 (C-7), 116.6 (C-5), 112.9 (C-
8), 64.0 (C-2), 57.6 (CH2AOAC‚O), 55.5 (OACH3), 54.0
(NACH2APh); ESIMS: m/z 378[M+H]
+; Anal. Calc. for
C21H19N3O4: C, 66.83; H, 5.07; N, 11.13. Found: C, 66.90;
H, 5.01; N, 11.19%.
2.3.11. [1-(2-Morpholino-2-oxoethyl)-1H-1,2,3-triazol-4-
yl]methyl 6-methoxy-2H-3-chromenecarboxylate (4dii)
Yield: 90%; Yellow solid;Mp: 167–169 C; IR (KBr): 1690 cm1
(CON), 1715 cm1 (COO); 1H NMR (DMSO-d6, 300 MHz): d
8.11 (1H, s, H-50), 7.51 (1H, s, H-4), 7.01 (1H, dd, J= 7.8 Hz,
J= 2.1 Hz, H-7), 7.01–6.87 (2H, m, H-8, H-6), 5.49 (2H, s,
NACH2), 5.31 (2H, s, COOCH2), 4.91 (2H, s, OCH2), 3.76
(3H, s, 6-OCH3), 3.65–3.57 (4H, 2t, J= 4.2 Hz, O(CH2)2),
3.52–3.38 (4H, 2t, J= 4.2 Hz, N(CH2)2);
13C NMR (CDCl3,
75.5 MHz): d 164.2 (NAC‚0), 163.3 (OAC‚O), 154.2 (C-
8(a), 149.1 (C-6), 134.4 (C-4), (C-50), 125.9 (C-40), 122.6 (C-3),
121.3 (C-4(a), 117.9 (C-7), 116.7 (C-5), 113.0 (C-8), 66.4 (C-
300), 66.2 (C-500), 64.2 C-2), 57.7 (ACH2AOAC‚O), 55.6 (6-
OCH3), 50.7 (NACH2APh), 45.6 (C-200), 42.4 (C-600); ESIMS:
m/z 415[M+H]+; Anal. Calc. for C20H22N4O6: C, 57.97; H,
5.35; N, 13.52. Found: C, 57.86; H, 5.42; N, 13.47%.
2.3.12. [1-(3-Morpholino-3-oxopropyl)-1H-1,2,3-triazol-4-
yl]methyl 6-methoxy-2H-3-chromenecarboxylate (4diii)
Yield: 87%; Yellow solid; Mp: 98–100 C; IR (KBr): 1690 cm1
(CON), 1730 cm1 (COO); 1H NMR (DMSO-d6, 300 MHz): d
8.20 (1H, s, H-50), 7.49 (1H, s, H-4), 7.01 (1H, d, J= 2.9 Hz,
H-5), 6.86 (1H, dd, J= 2.7 Hz, J= 8.4 Hz, H-7), 6.80 (1H, d,
J= 8.4 Hz, H-8), 5.36 (2H, s, COOCH2), 4.85 (2H, s, OCH2),
4.58 (2H, t, J= 5.9 Hz, NACH2), 3.52 (4H, m, 300,500-(CH2)2),
3.41 (4H, m, 200,600-(CH2)2), 3.0 (2H, t, J= 5.9 Hz, CH2CO);
13C NMR (CDCl3, 75.5 MHz): d 167.7 (NAC‚O), 164.0
(OAC‚O), 154.1 (C-8(a), 148.9 (C-6), 142.1 (C-40), 134.1
(C-4), 125.2 (C-50), 122.5 (C-3), 121.1 (C-4(a), 117.7 (C-7),
116.6 (C-5), 112.9 (C-8), 66.4 (C-300), 66.1 (C-500), 64.0 (C-2),
57.5 (CH2AOAC‚O), 55.5 (6-OCH3), 45.7 (C-200), 45.4 (C-
600), 41.8 (NACH2APh), 32.9 (CH2AC‚O); ESIMS: m/z
429[M+H]+; Anal. Calc. for C21H24N4O6: C, 58.87; H, 5.65;
N, 13.08. Found: C, 58.98; H, 5.59; N, 13.21%.
2.3.13. (1-Benzyl-1H-1,2,3-triazol-4-yl)methyl 8-methoxy-2H-
3-chromenecarboxylate (4ei)
Yield: 90%; white solid; Mp: 139–141 C; IR (KBr): 1690 cm1
(C‚O); 1H NMR (DMSO-d6, 400 MHz): d 8.24 (1H, s, H-50),
7.45 (1H, s, H-4), 7.38–7.31 (5H, m, H-200,300,400,500,600), 7.02 (1H,
d, J= 7.4 Hz, H-5), 6.95–6.87 (2H, m, H-6, H-7), 5.61 (2H, s,
NACH2), 5.24 (2H, s,COOCH2), 4.90 (2H, s, OCH2), 3.78 (3H,
s, 8-OCH3);
13C NMR (CDCl3, 75.5 MHz): d 164.0
(C‚O),147.7 (C-8, C-8(a),142.8 (C-40), 134.2 (C-6, C-3, C-
100), 129.0 (C-300, C-500), 128.7 (C-200, C-600), 128.0 (C-400), 123.7
(C-50), 121.7 (C-4(a), 121.3 (C-4), 120.8 (C-5), 114.5 (C-7),
64.4 (C-2), 57.6 (CH2AOAC‚O), 55.9 (8-OCH3), 54.0
(NACH2APh); ESIMS: m/z 377[M+H]
+; Anal. Calc. for
C21H19N3O4: C, 66.83; H, 5.07; N, 11.13. Found: C, 66.87;



















Figure 1 NOE representation of triazole proton.
376 M. Koteswara Reddy et al.2.3.14. [1-(2-Morpholino-2-oxoethyl)-1H-1,2,3-triazol-4-
yl]methyl 8-methoxy-2H-3-chromenecarboxylate (4eii)
Yield: 92%; yellow solid; Mp: 146–148 C; IR (KBr): 1690 cm1
(CON), 1725 cm1 (COO); 1H NMR (CDCl3, 400 MHz): d
7.87 (1H, s, H-50), 7.46 (1H, s, H-4), 6.88 (1H, m, H-7, H-5),
6.77 (1H, m, H-6), 5.38 (2H, s, NACH2), 5.24 (2H, s,
COOCH2), 5.04 (2H, s, OCH2), 3.87 (3H, s, 8-OCH3), 3.64–
3.56 (4H, 2t, J= 4.1 Hz, O(CH2)2), 3.53–3.41 (4H, 2t,
N(CH2)2);
13C NMR (CDCl3, 75.5 MHz): d 163.7 (NAC‚O),
163.2 (OAC‚O), 147.4 (C-8, C-8(a), 143.5 (C-40), 133.8 (C-3),
121.4 (C-50), 121.1 (C-6, C-4), 121.0 (C-4(a), 120.6 (C-5), 114.3
(C-7), 66.0 (C-300), 65.8 (C-500), 64.1 (C-2), 57.4 (CH2COO),
55.6 (8-OCH3), 50.4 (NACH2), 45.0(C-200), 42.0 (C-600);
ESIMS: m/z 415[M+H]+; Anal. Calc. for C20H22N4O6: C,
57.97; H, 5.35; N, 13.52. Found: C, 57.89; H, 5.28; N, 13.61%.
2.3.15. [1-(3-Morpholino-3-oxopropyl)-1H-1,2,3-triazol-4-
yl]methyl 8-methoxy-2H-3-chromenecarboxylate (4eiii)
Yield: 86%; yellow solid; Mp: 88–90 C; IR (KBr): 1685 cm1
(CON), 1720 cm1 (COO); 1H NMR (CDCl3, 400 MHz): d
7.81 (1H, s, H-50), 7.45 (1H, s, H-4), 6.91 (2H, m, H-7, H-5),
6.77 (1H, m, H-6), 5.34 (2H, s, COOCH2), 4.97 (2H, s,
OCH2), 4.72 (2H, t, J= 5.9 Hz, NACH2), 3.65 (3H, s, 8-
OCH3), 3.40 (4H, t, J= 4.4 Hz, 3
00,500-(CH2)2), 2.99 (4H, t,
J= 4.4 Hz, 200,600-(CH2)2), 2.56 (2H, t, J= 5.9 Hz, CH2CO);
13C NMR (CDCl3, 75.5 MHz): d 168.0 (NAC‚O), 164.1
(OAC‚O), 149.3(C-8, C-8(a), 142.2 (C-40), 134.6(C-3), 124.9
(C-50), 121.8 (C-6), 120.7 (C-4), 117.7 (C-4(a), 116.6 (C-5),
116.0 (C-7), 66.5 (C-300), 66.3 (C-500), 64.2 (C-2), 58.5
(CH2COO), 57.7 (8-OCH3), 45.9 (C-2
00), 45.6 (C-600),
42.0(NACH2), 33.0 (CH2CO); ESI MS: m/z 429[M+H]
+;
Anal. Calc. for C21H24N4O6: C, 58.87; H, 5.65; N, 13.08.
Found: C, 58.93; H, 5.70; N, 13.17%.
3. Results and discussion
3.1. Chemistry
The aim of present work was to develop simple and efﬁcient
procedure for the preparation of new chromene derivatives
bearing substituted 1,2,3-triazole moiety. 3-Cyano-2H-chrom-
enes 1a–e and 2H-chromene-3-carboxylic acids 2a–e prepared
according to literature procedure (Subramanian, 2001), the
key intermediates 2-propynyl-2H-chromene-3-carboxylates
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1a. R1 = R2 = H                             2a                                           3a      
1b. R1 = CH3 , R2 = H                  2b                                           3b      
1c.R1 = Cl, R2 = H                        2c                                           3c       
1d. R1 = OCH3 , R2 = H               2d                                          3d       
1e. R1 = H , R2 = OCH3                     2e                                           3e       
a b
Scheme 1 Synthesis of (1-alkyl-1H-1,2,3-triazol-4-yl) methyl-2H-chr
100 C; (b) SOCl2 , propargyl alchol , TEA; (c) R3CH2N3 , CuSO4Æ5Halchol (Scheme 1).The structures of 3a–e characterized by spec-
tral analysis. Compound 3a in its IR showed peaks at 2150 cm1
(C„C) and 1685 cm1 (CO). In the 1H NMR of 3a the char-
acteristic protons of propargyl group appeared at d 4.79 (d,
J= 2.4 Hz, COOCH2), d 2.77 (d, J= 2.4 Hz, C„CAH), the
chromene protons resonated at d 7.53 (s H-4), 7.12 (d,
J= 7.5 Hz, H-5), d 6.97 (ddd, J= 7.5 Hz, J= 7.3 Hz,
J= 1.3 Hz, H-6), d 6.82 (d, J= 8.1 Hz, H-8), d 4.99 (s,
OCH2). In
13C NMR of 3a the signals due to propargyl moiety
are at d 77.4 (C-40), d 75.1(C-50), the ester carbonyl appeared at
d 163.4 and the signals due to chromene moiety appeared at d
52.0, (OCH2), 155.1 (C-8(a), 134.5 (C-7), 132.1 (C-4), 128.9
(C-5), 121.6 (C-6), 121.3 (C-3), 120.5 (C-4(a), 116.0 (C-8),
64.1 (C-2). MS m/z 215[M+H]+.
The azides (i–iii) are prepared by the reaction of substituted
alkyl halides with sodium azide in DMF medium (Escaicu et
al., 2008).
2-Propynyl-2H-chromene-3-carboxylates 3a–e on reaction
with different azides in the presence of CuSO4.5H2O and
sodium ascorbate in water and t-BuOH affords exclusively
1,4-regioisomers of 1H-1,2,3-triazol-4-yl)methyl 2H-chro-
mene-3-carboxylates (4ai–4eiii) in good yields (Scheme 1). The
1,5-regioisomer formation not observed. The compounds
(4ai–4eiii) were characterized from IR, 1H NMR, 13C NMR,
NOESY and MS data. In the IR of (1-benzyl-1H-1,2,3-triazol-
4-yl)methyl 2H-chromene-3-carboxylate 4ai, the peak observed
at 1725 cm1 is due to CO of ester. In the 1H NMR of 4ai,
the proton of the newly formed triazole ring, H-50 appeared
at d 8.30 as singlet. The benzyl CH2 protons appeared as a singlet
at d 5.61, aromatic protons of phenyl appeared at d 7.38–7.33
(H-200, H-600, H-300, H-400, H-500, H-5), the COOCH2 appeared as
a singlet at d 5.28. The chromene protons appeared at d 7.52
(s, H-4), d 7.28 (ddd, J= 7.6 Hz, J= 8.0 Hz, J= 1.6 Hz,
H-7), d 6.86 (d, J= 8.0 Hz, H-8), d 6.96 (ddd, J= 7.6 Hz,
J= 7.2 Hz, J= 1.6 Hz, H-6) and d 4.93 (s, 2-OCH2). The
regioselective formation of 1,4-regioisomer, (1-benzyl-1H-
1,2,3-triazol-4-yl)methyl 2H-chromene-3-carboxylate 4ai rather
than 1,5-regioisomer (1-benzyl-1H-1,2,3-triazol-5-yl) methylN O





























                                                           4ai-4aiii
                                                           4bi-4biii
                                                           4ci-4ciii
                                                           4di-4diii
                                                           4ei-4eiii
c
omene-3-carboxylates. Reagents and conditions: (a) 10% NaOH,
2O, sodium ascorbate , t-BuOH/H2O.
Table 1 Antibacterial activity.
Bacillus subtilis (Gram-positive)
(Conc. lg/mL) zone of inhibition mm)
Pseudomonas aerogenosa (Gram-negative)
(Conc. lg/mL) zone of inhibition mm
Staphylococus aureus (Gram-positive)
(Conc. lg/mL) zone of inhibition mm
Comp 200 100 50 Comp 200 100 50 Comp 200 100 50
4ai 14.0 12.0 9.0 4ai 12.5 8.5 6.0 4ai 29.5 16.0 11.0
4aiii 22.0 16.0 – 4aiii 19.5 – 13.5 4aii 32.5 14.0 8.0
4biii 20.0 12.0 7.0 4biii 28.0 21.0 13.0 4bii 29.5 19.5 12.5
4ci 11.0 12.5 – 4ci 19.5 – 16.5 4biii 21.5 12.5 8.0
4ciii 17.5 20.0 7.5 4cii – 10.5 – 4ci 12.5 – 14.0
4dii 27.0 21.0 19.0 4ciii – 5.0 4.0 4dii 18.0 14.5 –
4diii – 11.0 – 4diii 14.0 7.0 5.0 4diii 14.5 10.0 5.0
4eii 15.0 12.0 9.0 4ei 26.0 18.0 11.0 4ei 22.0 12.5 4.0
4eiii 13.5 20.5 10.0 4eiii 17.0 – 10.0 4eiii 19.0 13.0 –
Ref. 31.0 25.0 20.0 Ref. 32.0 22.0 14.5 Ref. 34.0 30.0 25.0
Table 2 Antifungal activity.
Aspergillus niger (Conc. lg/mL) zone
of inhibition mm
Rhizoctonia solani (Conc. lg/mL) zone
of inhibition mm
Aspergillus terreus (Conc. lg/mL) zone
of inhibition mm
Comp 200 100 50 Comp 200 100 50 Comp 200 100 50
4aii 17.5 8.0 04.0 4aiii 16.5 09.0 06.0 4ai 22.0 13.0 04.0
4aiii – 12.0 09.0 4bi 15.0 11.0 11.5 4aiii 14.0 09.5 08.0
4bi 32.0 19.0 05.0 4bii – 06.0 03.5 4bi 16.0 09.0 04.0
4bii 21.0 – – 4biii 23.0 09.5 04.5 4bii 24.0 – –
4cii 24.0 19.0 14.0 4ci 17.5 10.5 08.0 4ci 25.0 19.0 14.0
4ciii – – 07.0 4ciii 18.0 – – 4cii 15.0 12.0 –
4diii 16.0 22.0 04.0 4dii 15.0 04.0 – 4ciii 12.5 11.0 04.0
4ei 15.0 – 05.0 4diii 23.0 18.0 12.0 4dii 21.0 – –
4eii 28.0 20.0 – 4eiii 22.0 – 08.5 4eiii 15.0 11.5 10.0
Ref. 32.0 23.5 17.0 Ref. 30.0 22.0 15.0 Ref. 30.0 22.0 24.0
Synthesis and anti-microbial activity 3772H-chromene-3-carboxylate is conﬁrmed from the analysis of
NOESY spectrum (Fig. 1). The triazole proton at d 8.30
showed a strong NOE with the NACH2 at d 5.61 and COOCH2
at d 5.28 and a medium NOE with the protons of the phenyl
ring. The H-4 at d 7.52 showed a weak NOE with 2-OCH2 at d
4.93 and COOCH2 at d 5.28. These NOE values are possible
only for the 1,4-regioisomer. In the 13C NMR the 40-OCH2
appeared at d 57.6 and the two triazole carbons at d 142.8
(C-40, C-100), d 123.7 (C-50), the benzylic carbon at d 54.0 and
the ester carbonyl at d164.1. The chromenyl moiety carbons
appeared as follows d 154.9 (C-8(a), 134.2 (C-7), 131.9
(C-4),128.9 (C-5),128.8 (C-300),(C-500),128.6 (C-200),(C-600), 127.9
(C-400), 121.6(C-6),120.5 (C-3),(C-4(a),115.9 (C-8) and 64.1
(C-2). In the ESIMS of 4ai the quasimolecular ion peak was
observed at m/z 348[M+H]+.
3.2. Antimicrobial activity
The in vitro antimicrobial activity (Atwal et al., 1993; Pfef-
ferle et al., 1990; Ayer and Nozawa, 1990) of all the synthe-
sized compounds were carried out using paper disk method,
the compounds screened against Bacillus subtilis (Gram-posi-
tive), Staphylococus aureus (Gram-positive), Pseudomonas
aerogenosa (Gram-negative) antibacterial as well as Aspergil-
lus niger, Rhizoctonia solani and Aspergillus terreus antifungalstrains. The strains used for the activity procured from IMT,
Chandigarah. Cultures of test organisms were maintained on
nutrient agar (bacterial) and potato dextrose agar (fungal)
media and subcultured in petri dishes prior to testing. The
compounds are tested at concentrations 200 lg/mL, 100 lg/
mL, 50 lg/mL using DMSO as solvent. After solidiﬁcation
of media, petri plates inoculated with actively growing cul-
tures of B. subtilis (Gram-positive), S. aureus (Gram-posi-
tive), P. aerogenosa (Gram-negaitive) and A. niger, R.
solani, A. terreus separately. Filter paper disks of 5 mm diam-
eter dipped in the test solution of different concentrations.
After drying the disk, kept on nutrient agar broth. Potato
dextrose broth in petri plates seeded with 1 mL culture of
B. subtilis (Gram-positive), P. aerogenosa (Gram-negative),
S. aureus (Gram-positive) and A. niger, R. solani, A. terreus
incubated for 24 h at 27 C. After 2 h the petri dishes were
tested for growth of inhibition. The presence of clear zone
of growth inhibition around the paper disk indicated the
inhibition of growth of organisms. The diameter of zone of
inhibition was calculated in millimeters, ampicillin is used
as standard antibacterial drug, where as clotrimazole used
as standard antifungal drug.
The examination of data (Tables 1 and 2) reveals that com-
pound 4biii, 4ei having comparable activity with standard drug
against P. aerogenosa at 200 lg/mL, 100 lg/mL compound
378 M. Koteswara Reddy et al.4dii shown high activity at 50 lg/mL against B. subtilis and4ai,
4aii, 4bii showed high activity against S. aureus at 200 lg/mL.
Compounds 4bi, 4eii exhibited activity against A. niger compa-
rable to that of reference drugs at 200 lg/mL, 100 lg/mL,
remaining all the other compounds showed low to moderate
activity.
4. Conclusion
Herewith, we report the simple and efﬁcient method of synthe-
sis of novel mixed heterocyclic compounds, (1-alkyl-1H-1,2,3-
triazol-4-yl)methyl-2H-chromene-3-carboxylates (4ai–4eiii).
Some of these compounds have shown good antimicrobial
activity. Hence chromene – triazole derivatives can be used
in future for drug designing and development.
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